DiaCarta is a translational genomics and personalized diagnostics company that provides ultra-sensitive detection tools for cancer diagnosis, therapy identification and prognosis monitoring. Our mission is to provide ultra-sensitive and advanced technologies that will redefine the way molecular diagnostics and translational genomics impact healthcare treatment plans and the well-being of individuals around the world. To learn more, visit http://www.diacarta.com.

Precision Molecular Diagnostics Translational Genomics CLIA Lab XNA Technology SuperbDNA Technology NGS Liquid Biopsy Cancer Mutation Detection Colorectal Cancer Mutation Detection In-Vitro Diagnostics Precision Medicine Personalized Radiation Therapy HPV mRNA Test Cervical Cancer Screening Head and Neck Cancer Screening Early Cancer Detection CAR-T and Immuno therapy Whole Genome Sequencing B2B Biotech SaaS Commercial Physical Research Biotechnology